ClinicalTrials.gg
Drug

Rosiglitazone clinical trials

Also written Avandia.

studies test it
148
open now
1
in phase 3
42
first study started
1998

How each study uses Rosiglitazone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Rosiglitazone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 May 1999 · AVANDIA · NDA 021071 (FDA, Drugs@FDA)
European Union
11 Jul 2000 · Avandia · EMEA/H/C/000268 (EMA; now expired)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rosiglitazone
106
rosiglitazone maleate
11
Rosiglitazone XR
4
Rosiglitazone Extended Release 2mg
2
Rosiglitazone Extended Release 8mg
2

Brand

Avandia
31

Development codes

BRL49653
1
BRL 49653C
1

In one entry with another drug

Given together, or one or the other

rosiglitazone/metformin
3

Studies by the year they started

142 studies that test it; most in 2006 (27)

Studies that test Rosiglitazone, by start year
YearStudies
19981
19992
20007
20016
200210
200313
200417
200526
200627
200714
200811
20092
20103
20162
20201

By phase

A phase 1/2 study counts in both.

Phase 1
19
Phase 2
36
Phase 3
42
Phase 4
36
No phase
23

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 54 · Other 94

GlaxoSmithKline (41) · Novo Nordisk A/S (4) · University of Glasgow (3) · University of Washington (2) · James Lewis (2) · Stanford University (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Massachusetts General Hospital (2)

Often tested with

Tested in the same studies.

Metformin (20) · Glyburide (3) · Flurbiprofen (3) · Glimepiride (3) · Fenofibrate (3) · Pioglitazone (3) · Ramipril (3) · Liraglutide (2)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Rosiglitazone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 148

See all 148 studies that test Rosiglitazone →

Given beside what is tested · 8 — Rosiglitazone is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with Rosiglitazone

Codes

What other systems call Rosiglitazone · ClinicalTrials.gg INT006654

  • MeSH (NLM) D000077154RosiglitazoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 05V02F2KDGROSIGLITAZONEConfirmed FDA, NLM, Wikidata
  • RxNorm 84108Confirmed FDA, Wikidata
  • Wikidata Q424771(RS)-rosiglitazoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62076RosiglitazoneOne source FDA
  • DrugBank DB00412One source Wikidata

Also registered as rosiglitazone maleate (UNII KX2339DP44 · RxNorm 253198).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.